9939 — Kintor Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$411.70m
- HK$192.49m
Annual cashflow statement for Kintor Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -233 | -508 | -842 | -953 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.84 | 134 | 66.5 | 173 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.97 | -13.4 | -286 | -199 | -388 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -228 | -381 | -1,051 | -961 | -388 |
| Capital Expenditures | -74.1 | -96.2 | -106 | -27.6 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 67.1 | -344 | 198 | 94.8 | 3.27 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.01 | -440 | 92 | 67.2 | 3.27 |
| Financing Cash Flow Items | 305 | -29.1 | -2.03 | 0 | -33.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 296 | 1,780 | 857 | 816 | -33.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 58 | 869 | -138 | -61.9 | -420 |